MP38-10 WINDOW OF OPPORTUNITY STUDY EVALUATING THE ANTIPROLIFERATIVE EFFECTS OF NEOADJUVANT METFORMIN PLUS SIMVASTATIN PRIOR TO RADICAL CYSTECTOMY FOR BLADDER CANCER: INTERIM ANALYSIS SHOWS REDUCTION IN PI3K/AKT/MTOR SIGNALING PATHWAY